Table 3.
Univariate and multivariate analyses of biochemical recurrence in the study cohort.
| Factors | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| HR (95% CI) | p value | HR (95% CI) | p value | |
| Age (years) | 1.203 (0.639 - 2.265) | 0.568 | ||
| Gleason grade | 2.844 (2.165 - 3.376) | 0 | 1.537 (1.149 - 2.057) | 0.004 |
| PSA (ng/mL) | 1.035 (0.550 - 1.950) | 0.914 | ||
| TNM staging | 38.722 (11.641 - 128.871) | 0 | 8.725 (2.368 - 32.178) | 0.001 |
| Risk stratification | 7.689 (3.632 - 16.278) | 0 | 4.037 (1.454 - 11.206) | 0.007 |
| LSAMP-AS1 | 0.285 (0.141 - 0.573) | 0 | 0.371 (0.166 - 0.830) | 0.016 |
| DCN | 0.462 (0.240 - 0.889) | 0.021 | 0.430 (0.211 - 0.877) | 0.02 |
Note: PSA, prostate specific antigen; TNM, tumor node metastasis; DCN, Decorin; HR, hazard ratio; CI, confidence interval.